Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical... see more

CSE:IMCC - Post Discussion

IM Cannabis Corp > IMCC Managment - Stop Blaming the Market Trends!!
View:
Post by Believe1010 on Jun 17, 2022 12:29pm

IMCC Managment - Stop Blaming the Market Trends!!

To all the management and current mareketing team.  I would say there is no excuse for this. There are other cannabis companies that have not had these type of drops in stock price like IMCC. You apparently have great sales that are increasing. You apparently have a great team that knows public markets and how to keep shareholder value, you apparently have a fudiciary duty to shareholders, you apparently have a public marketing team, you apparently are paying healthy salaries to employees, you apparently have international sales increasing, you apparently have the no.1 and 2 products selling in Canada, you apparently know how to keep a burn rate down in running a company, you apparently know your about to be delisted off Nasdaq, you are apparently have billionaires and mulitimilionaires who own it. Soooo.... do something about it before you really lose everyone!!! Unless... as I wrote early in my crystal ball.. you plan to run this down so cheap that you buy it back through a sub company and take it private leaving all of us shareholders with nothing. Then that would call for a something else... Have some intergrity if you have all the things I mentioned above and buy some shares instead of watching your company be a joke!!
Comment by RockMaschine on Jun 20, 2022 10:58am
CEO bought almost a half million on the open market at $2.85CDN, which is practically book value for the company. Likely did it because soon after would be a black out period between reporting events. I expect news soon of Highland and Wagners being sold in Quebec. Within a few months there will be big news out of Germany. I need to clarify if Israel has changed rules regarding imports and how ...more  
Comment by NLMoose on Jun 21, 2022 9:03am
If Highland Grow and Wagner's are sold, that would be against their takeover agreement with the brand's former owners, MYM Nutraceuticals and Biome Grow. Part of MYM Nutraceuticals' agreement with IM Cannabis was that the Highland Grow brand would remain with the new company, not sold to someone else.  
Comment by RockMaschine on Jun 21, 2022 11:29am
It would be the entire IM Cannabis organization that would be sold. Which means Focus medical and Adjupharm, along with Panaxia and all the other pharmacies acquired. Not going to happen, the company is just one the kind who do things and don't say anything. Beyond unknown in the sector and susceptible to Nasdaq games without the size and liquidity to have attacks on share price fended off ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities